Literature DB >> 20738968

[Inherited epidermolysis bullosa: from diagnosis to reality].

A Hernández-Martín1, A Torrelo.   

Abstract

Inherited epidermolysis bullosa (EB) refers to a group of diseases that is well-known to dermatologists. The diagnosis of an EB disease, which is usually straightforward, is devastating for affected families. The manifestations of forms of EB run well beyond the boundaries of dermatology, as patients frequently present a wide range of associated systemic conditions that can be considerably more severe than the skin disease itself. As dermatologists, we must be aware of the potential complications of EB because our intervention is essential for the correct referral of patients and coordination of all the specialists involved in their care.

Entities:  

Mesh:

Year:  2010        PMID: 20738968     DOI: 10.1016/s1578-2190(10)70834-9

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


  3 in total

1.  The analysis of echocardiographic results in patients suffering from epidermolysis bullosa.

Authors:  Katarzyna Kurnicka; Katarzyna Osipowicz; Olga Dzikowska-Diduch; Katarzyna Wertheim-Tysarowska; Cezary Kowalewski; Piotr Pruszczyk
Journal:  Postepy Dermatol Alergol       Date:  2021-01-06       Impact factor: 1.837

2.  Prioritization of therapy uncertainties in Dystrophic Epidermolysis Bullosa: where should research direct to? an example of priority setting partnership in very rare disorders.

Authors:  Paula Davila-Seijo; Angela Hernández-Martín; Evanina Morcillo-Makow; Raúl de Lucas; Esther Domínguez; Natividad Romero; Eva Monrós; Marta Feito; Luis Carretero; Bea Aranegui; Ignacio García-Doval
Journal:  Orphanet J Rare Dis       Date:  2013-04-22       Impact factor: 4.123

3.  Inherited epidermolysis bullosa: clinical and therapeutic aspects.

Authors:  Vanessa Lys Simas Yamakawa Boeira; Erica Sales Souza; Bruno de Oliveira Rocha; Pedro Dantas Oliveira; Maria de Fátima Santos Paim de Oliveira; Vitória Regina Pedreira de Almeida Rêgo; Ivonise Follador
Journal:  An Bras Dermatol       Date:  2013 Mar-Apr       Impact factor: 1.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.